• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Application of Methyl 5-Nitropyridine-2-Carboxylate (CAS 29682-14-2) in Chemical Biology and Pharmaceutical Research

Methyl 5-nitropyridine-2-carboxylate (CAS 29682-14-2) is a versatile chemical intermediate that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its nitro and ester functional groups, serves as a key building block in the synthesis of various heterocyclic compounds, which are often explored for their biological activities. Recent studies have highlighted its utility in the development of novel therapeutic agents, particularly in the fields of oncology, infectious diseases, and neurological disorders.

One of the most notable advancements involving methyl 5-nitropyridine-2-carboxylate is its role in the synthesis of kinase inhibitors. Kinases are critical targets in cancer therapy, and researchers have leveraged the reactivity of this compound to design potent and selective inhibitors. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated the use of methyl 5-nitropyridine-2-carboxylate as a precursor in the synthesis of pyridine-based inhibitors targeting the epidermal growth factor receptor (EGFR), a protein implicated in various cancers. The study reported improved inhibitory activity and reduced off-target effects compared to previous generations of inhibitors.

In addition to its applications in oncology, methyl 5-nitropyridine-2-carboxylate has been explored as a scaffold for antimicrobial agents. A recent publication in Bioorganic & Medicinal Chemistry Letters detailed the synthesis of a series of nitropyridine derivatives using this compound, which exhibited potent activity against drug-resistant bacterial strains. The researchers attributed the enhanced efficacy to the electron-withdrawing nitro group, which facilitates interactions with bacterial enzymes. These findings underscore the potential of methyl 5-nitropyridine-2-carboxylate in addressing the growing challenge of antibiotic resistance.

Beyond its therapeutic applications, methyl 5-nitropyridine-2-carboxylate has also been investigated for its utility in chemical biology. A 2022 study in ACS Chemical Biology described its use as a fluorescent probe for detecting reactive oxygen species (ROS) in cellular environments. The nitro group in the compound undergoes reduction in the presence of ROS, leading to a measurable change in fluorescence. This property makes it a valuable tool for studying oxidative stress, which is implicated in numerous diseases, including neurodegenerative disorders and cardiovascular conditions.

The synthetic versatility of methyl 5-nitropyridine-2-carboxylate has further been demonstrated in the development of prodrugs. Prodrugs are inactive compounds that are metabolized into active drugs within the body, often improving bioavailability or reducing side effects. A recent study in European Journal of Medicinal Chemistry highlighted the use of this compound in the design of prodrugs for central nervous system (CNS) agents. The researchers successfully synthesized a prodrug that exhibited enhanced blood-brain barrier penetration, paving the way for improved treatments for neurological disorders.

Despite its promising applications, challenges remain in the large-scale production and optimization of methyl 5-nitropyridine-2-carboxylate-based compounds. Issues such as yield, purity, and scalability need to be addressed to facilitate their transition from the laboratory to clinical use. However, ongoing research efforts, including the development of novel synthetic routes and catalytic methods, are expected to overcome these hurdles. For example, a 2023 study in Organic Process Research & Development reported a more efficient and environmentally friendly synthesis of methyl 5-nitropyridine-2-carboxylate using green chemistry principles, which could significantly enhance its industrial applicability.

In conclusion, methyl 5-nitropyridine-2-carboxylate (CAS 29682-14-2) continues to be a compound of great interest in chemical biology and pharmaceutical research. Its diverse applications, ranging from kinase inhibitors to antimicrobial agents and fluorescent probes, highlight its potential to contribute to the development of next-generation therapeutics. As research progresses, it is anticipated that this compound will play an increasingly important role in addressing unmet medical needs and advancing our understanding of biological systems.

• 30651-24-2(5-nitropyridine-2-carboxylic acid)
• 229343-13-9(Ethyl 3-nitropyridine-2-carboxylate)
• 103698-08-4(Methyl 3-nitropyridine-2-carboxylate)
• 29681-41-2(Methyl 4-Nitropicolinate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)